Concepedia

Zhenwei Su

ZS

10

Publications

506

Citations

10

H-Index

2015

Active since

Affiliations

Sun Yat-sen University(Current)

Second Affiliated Hospital of Guangzhou Medical University

Guangzhou Medical University

Jinan University

Southern University of Science and Technology

Zhenwei Su is an author at Sun Yat-sen University specializing in medicine, nanomedicine, and biomedical engineering.

Top concepts

MedicineNanomedicineEngineeringNanoparticlesRadiation OncologyBiomedical EngineeringImmunologyImmunotherapyTumor ImmunityImmuno-oncology

Publications per year

2015–2025

10

Publications

10

Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy

Zecong Xiao, Zhenwei Su, Shisong Han et al. · Science Advances · 2020 · 150 citations · Full text

Codelivery of Anti‐PD‐1 Antibody and Paclitaxel with Matrix Metalloproteinase and pH Dual‐Sensitive Micelles for Enhanced Tumor Chemoimmunotherapy

Zhenwei Su, Zecong Xiao, Yong Wang et al. · Small · 2020 · 116 citations

Dual-Sensitive PEG-Sheddable Nanodrug Hierarchically Incorporating PD-L1 Antibody and Zinc Phthalocyanine for Improved Immuno-Photodynamic Therapy

Zhenwei Su, Zecong Xiao, Jinsheng Huang et al. · ACS Applied Materials & Interfaces · 2021 · 54 citations

Immunology, Improved Immuno-photodynamic Therapy, Zinc Phthalocyanine +20

Microfluidics‐enabled Serial Assembly of Lipid‐siRNA‐sorafenib Nanoparticles for Synergetic Hepatocellular Carcinoma Therapy

Yao Chen, Dong Zhao, Feng Xiao et al. · Advanced Materials · 2023 · 42 citations

Microfluidics‐Enabled Nanovesicle Delivers CD47/PD‐L1 Antibodies to Enhance Antitumor Immunity and Reduce Immunotoxicity in Lung Adenocarcinoma

Zhenwei Su, Shaowei Dong, Yao Chen et al. · Advanced Science · 2023 · 31 citations · Full text

Nanoparticles, Engineering, Cd47/pd-l1 Antibodies Combination +22

Rows per page

1–5 of 10